- Home
- SGRY vs VCYT Comparison
SGRY vs VCYT Comparison
Compare SGRY & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRY
- VCYT
- Stock Information
- Founded
- SGRY 2004
- VCYT 2006
- Country
- SGRY United States
- VCYT United States
- Employees
- SGRY N/A
- VCYT N/A
- Industry
- SGRY Hospital/Nursing Management
- VCYT Medical Specialities
- Sector
- SGRY Health Care
- VCYT Health Care
- Exchange
- SGRY Nasdaq
- VCYT Nasdaq
- Market Cap
- SGRY 2.8B
- VCYT 2.6B
- IPO Year
- SGRY 2015
- VCYT 2013
- Fundamental
- Price
- SGRY $21.15
- VCYT $36.00
- Analyst Decision
- SGRY Buy
- VCYT Buy
- Analyst Count
- SGRY 9
- VCYT 9
- Target Price
- SGRY $32.88
- VCYT $39.89
- AVG Volume (30 Days)
- SGRY 1.4M
- VCYT 956.5K
- Earning Date
- SGRY 11-11-2025
- VCYT 11-05-2025
- Dividend Yield
- SGRY N/A
- VCYT N/A
- EPS Growth
- SGRY N/A
- VCYT N/A
- EPS
- SGRY N/A
- VCYT 0.34
- Revenue
- SGRY $3,237,000,000.00
- VCYT $479,129,000.00
- Revenue This Year
- SGRY $9.85
- VCYT $14.28
- Revenue Next Year
- SGRY $9.47
- VCYT $9.83
- P/E Ratio
- SGRY N/A
- VCYT $107.24
- Revenue Growth
- SGRY 12.05
- VCYT 19.91
- 52 Week Low
- SGRY $18.87
- VCYT $22.61
- 52 Week High
- SGRY $33.37
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- SGRY 39.19
- VCYT 67.93
- Support Level
- SGRY $20.62
- VCYT $31.81
- Resistance Level
- SGRY $22.12
- VCYT $34.89
- Average True Range (ATR)
- SGRY 0.54
- VCYT 1.43
- MACD
- SGRY -0.05
- VCYT 0.16
- Stochastic Oscillator
- SGRY 31.18
- VCYT 84.60
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.